BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32745614)

  • 1. Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing.
    Avenarius MR; Miller CR; Arnold MA; Koo S; Roberts R; Hobby M; Grossman T; Moyer Y; Wilson RK; Mardis ER; Gastier-Foster JM; Pfau RB
    J Mol Diagn; 2020 Oct; 22(10):1238-1245. PubMed ID: 32745614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
    Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
    Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
    Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
    Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
    Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
    Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
    Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
    Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
    Claerhout S; Lehnert S; Vander Borght S; Spans L; Dooms C; Wauters E; Vansteenkiste J; Weynand B; Deraedt K; Bourgain C; Vanden Bempt I
    Lung Cancer; 2022 Apr; 166():242-249. PubMed ID: 35378489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA Sequencing.
    Al-Ibraheemi A; Putra J; Tsai HK; Cano S; Lip V; Pinches RS; Restrepo T; Alexandrescu S; Janeway KA; Duraisamy S; Harris MH; Church AJ
    J Mol Diagn; 2021 Oct; 23(10):1269-1278. PubMed ID: 34325058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and highly sensitive approach for multiplexed somatic fusion detection.
    Abbou S; Finstuen-Magro S; McDannell B; Feenstra M; Ward A; Shulman DS; Geoerger B; Duplan J; Comeau H; Janeway KA; Klega K; Crompton BD
    Mod Pathol; 2022 Aug; 35(8):1022-1033. PubMed ID: 35347250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indel sensitive and comprehensive variant/mutation detection from RNA sequencing data for precision medicine.
    Prodduturi N; Bhagwate A; Kocher JA; Sun Z
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):67. PubMed ID: 30255803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue Tumors.
    Chebib I; Taylor MS; Nardi V; Rivera MN; Lennerz JK; Cote GM; Choy E; Lozano Calderón SA; Raskin KA; Schwab JH; Mullen JT; Chen YE; Hung YP; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2021 Aug; 45(8):1127-1137. PubMed ID: 34115673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel exon-exon breakpoint in
    Loke BN; Lee VKM; Sudhanshi J; Wong MK; Kuick CH; Puhaindran M; Chang KTE
    J Clin Pathol; 2017 Aug; 70(8):697-701. PubMed ID: 28137728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of a Targeted RNA-Sequencing Panel in the Detection of Gene Fusions in Solid Tumors.
    Sun L; McNulty SN; Evenson MJ; Zhu X; Robinson JA; Mann PR; Duncavage EJ; Pfeifer JD
    J Mol Diagn; 2021 Dec; 23(12):1749-1760. PubMed ID: 34562614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.
    Kao YC; Sung YS; Zhang L; Huang SC; Argani P; Chung CT; Graf NS; Wright DC; Kellie SJ; Agaram NP; Ludwig K; Zin A; Alaggio R; Antonescu CR
    Am J Surg Pathol; 2016 Aug; 40(8):1009-20. PubMed ID: 26945340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
    Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
    Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
    Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
    Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
    Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
    Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate Genes in Testing Strategies for Linkage Analysis and Bioinformatic Sorting of Whole Genome Sequencing Data in Three Small Japanese Families with Idiopathic Superior Oblique Muscle Palsy.
    Matsuo T; Chaomulige ; Miyaji M; Hosoya O; Saito A; Nakazono K
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.